• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitiv

Giuseppe

Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]


Eurosurveillance, Volume 16, Issue 23, 09 June 2011

Rapid communications

Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation



A C Hurt ()<SUP>1</SUP>, R T Lee<SUP>2</SUP>, S K Leang<SUP>1</SUP>, L Cui<SUP>3</SUP>, Y M Deng<SUP>1</SUP>, S P Phuah<SUP>3</SUP>, N Caldwell<SUP>1</SUP>, K Freeman<SUP>4</SUP>, N Komadina<SUP>1</SUP>, D Smith<SUP>5</SUP>, D Speers<SUP>5</SUP>, A Kelso<SUP>1</SUP>, R T Lin<SUP>3</SUP>, S Maurer-Stroh<SUP>2</SUP><SUP>,3</SUP><SUP>,6</SUP>, I G Barr<SUP>1</SUP>
  1. World Health Organization Collaborating Centre for Reference and Research on Influenza, North Melbourne, Victoria, Australia
  2. Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore
  3. National Public Health Laboratory, Communicable Diseases Division Ministry of Health, Singapore
  4. Serology/Molecular Biology Department, Royal Darwin Hospital, Darwin, Australia
  5. PathWest Laboratory Medicine, Nedlands, Western Australia
  6. School of Biological Sciences (SBS), Nanyang Technological University (NTU), Singapore
<HR>
Citation style for this article: Hurt AC, Lee RT, Leang SK, Cui L, Deng YM, Phuah SP, Caldwell N, Freeman K, Komadina N, Smith D, Speers D, Kelso A, Lin RT, Maurer-Stroh S, Barr IG. Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill. 2011;16(23):pii=19884. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19884
Date of submission: 26 May 2011
<HR>A novel influenza A(H1N1)2009 variant with mildly reduced oseltamivir and zanamivir sensitivity has been detected in more than 10% of community specimens in Singapore and more than 30% of samples from northern Australia during the early months of 2011. The variant, which has also been detected in other regions of the Asia-Pacific, contains a S247N neuraminidase mutation. When combined with the H275Y mutation, as detected in an oseltamivir-treated patient, the dual S247N+H275Y mutant had extremely high oseltamivir resistance.

- -------
 
Back
Top Bottom